Cargando…

Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines

RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Kenji, Mizukoshi, Fuminori, Goto-Koshino, Yuko, Setoguchi-Mukai, Asuka, Fujino, Yasuhito, Ohno, Koichi, Tsujimoto, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117143/
https://www.ncbi.nlm.nih.gov/pubmed/17125939
http://dx.doi.org/10.1016/j.vetmic.2006.10.033
_version_ 1783514304529563648
author Baba, Kenji
Mizukoshi, Fuminori
Goto-Koshino, Yuko
Setoguchi-Mukai, Asuka
Fujino, Yasuhito
Ohno, Koichi
Tsujimoto, Hajime
author_facet Baba, Kenji
Mizukoshi, Fuminori
Goto-Koshino, Yuko
Setoguchi-Mukai, Asuka
Fujino, Yasuhito
Ohno, Koichi
Tsujimoto, Hajime
author_sort Baba, Kenji
collection PubMed
description RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small interfering RNAs (siRNAs) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV (CRFK/FIV). These synthetic siRNAs efficiently inhibited the replication of FIV. Next, we examined the effect of retroviral vector-mediated transfer of FIV-specific short hairpin RNA (shRNA) on the replication of FIV in a feline T-cell line chronically infected with FIV (FL4). The retroviral vector-mediated transfer of FIV-specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells. These results provide useful information for the development of RNAi-based gene therapy strategy to control FIV infection.
format Online
Article
Text
id pubmed-7117143
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71171432020-04-02 Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines Baba, Kenji Mizukoshi, Fuminori Goto-Koshino, Yuko Setoguchi-Mukai, Asuka Fujino, Yasuhito Ohno, Koichi Tsujimoto, Hajime Vet Microbiol Article RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small interfering RNAs (siRNAs) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV (CRFK/FIV). These synthetic siRNAs efficiently inhibited the replication of FIV. Next, we examined the effect of retroviral vector-mediated transfer of FIV-specific short hairpin RNA (shRNA) on the replication of FIV in a feline T-cell line chronically infected with FIV (FL4). The retroviral vector-mediated transfer of FIV-specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells. These results provide useful information for the development of RNAi-based gene therapy strategy to control FIV infection. Elsevier B.V. 2007-03-10 2006-11-27 /pmc/articles/PMC7117143/ /pubmed/17125939 http://dx.doi.org/10.1016/j.vetmic.2006.10.033 Text en Copyright © 2006 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Baba, Kenji
Mizukoshi, Fuminori
Goto-Koshino, Yuko
Setoguchi-Mukai, Asuka
Fujino, Yasuhito
Ohno, Koichi
Tsujimoto, Hajime
Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title_full Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title_fullStr Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title_full_unstemmed Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title_short Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
title_sort application of rna interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117143/
https://www.ncbi.nlm.nih.gov/pubmed/17125939
http://dx.doi.org/10.1016/j.vetmic.2006.10.033
work_keys_str_mv AT babakenji applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT mizukoshifuminori applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT gotokoshinoyuko applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT setoguchimukaiasuka applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT fujinoyasuhito applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT ohnokoichi applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines
AT tsujimotohajime applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines